Joint-Funding: Breakthrough T1D
Stem Cell Network
SCN and Breakthrough T1D are each providing up to $2,000,000 CAD to jointly fund regenerative medicine projects in the T1D area. Projects selected for joint funding will receive awards valued at up to 20% higher than SCN’s standard suite of awards. Each project selected for joint funding will be supported 50-50 by SCN and Breakthrough T1D.
The following SCN programs will be available for Joint-Funding Awards by SCN and Breakthrough T1D:
• Accelerating Clinical Translation Award: up to $840,000 per award over 22 months
• Impact Awards: up to $348,000 per award over 22 months
• Targeted call under the Impact Awards: ELSI & HE Stream exclusively for Access, Affordability and Adoption projects: up to $258,000 per award over 22 months
Deadlines
| UM Internal Deadline (to ADR) | Sponsor Deadline | |
|---|---|---|
Letter of Intent |
| 21-Sep-2026 11:59 pm PDT |
Application | 03-Nov-2026 | 24-Nov-2026 3:00 pm PDT |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.